Compare GSK Consumer with RASOYA PROTEINS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs RASOYA PROTEINS - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER RASOYA PROTEINS GSK CONSUMER/
RASOYA PROTEINS
 
P/E (TTM) x 39.1 2.6 1,515.3% View Chart
P/BV x 11.0 0.6 1,897.9% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 GSK CONSUMER   RASOYA PROTEINS
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
RASOYA PROTEINS
Mar-16
GSK CONSUMER/
RASOYA PROTEINS
5-Yr Chart
Click to enlarge
High Rs7,8191 1,117,057.1%   
Low Rs5,832NA 2,915,850.0%   
Sales per share (Unadj.) Rs1,136.90.4 253,651.1%  
Earnings per share (Unadj.) Rs233.7-2.3 -10,247.4%  
Cash flow per share (Unadj.) Rs248.1-2.2 -11,227.9%  
Dividends per share (Unadj.) Rs105.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs973.50.3 354,132.0%  
Shares outstanding (eoy) m42.061,708.93 2.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.01.0 598.0%   
Avg P/E ratio x29.2-0.2 -14,801.8%  
P/CF ratio (eoy) x27.5-0.2 -13,509.1%  
Price / Book Value ratio x7.01.6 428.3%  
Dividend payout %44.90-   
Avg Mkt Cap Rs m287,083769 37,331.1%   
No. of employees `0003.80.1 2,632.9%   
Total wages/salary Rs m6,44659 11,019.1%   
Avg. sales/employee Rs Th12,440.25,246.6 237.1%   
Avg. wages/employee Rs Th1,677.0400.7 418.5%   
Avg. net profit/employee Rs Th2,556.7-26,690.4 -9.6%   
INCOME DATA
Net Sales Rs m47,820766 6,242.8%  
Other income Rs m4,3267 60,929.6%   
Total revenues Rs m52,146773 6,745.1%   
Gross profit Rs m11,410-2,917 -391.2%  
Depreciation Rs m606121 499.6%   
Interest Rs m845 17.4%   
Profit before tax Rs m15,123-3,075 -491.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-928 0.0%   
Tax Rs m5,295-107 -4,962.4%   
Profit after tax Rs m9,828-3,897 -252.2%  
Gross profit margin %23.9-380.7 -6.3%  
Effective tax rate %35.03.5 1,009.1%   
Net profit margin %20.6-508.7 -4.0%  
BALANCE SHEET DATA
Current assets Rs m52,674111 47,462.8%   
Current liabilities Rs m18,1402,892 627.2%   
Net working cap to sales %72.2-363.1 -19.9%  
Current ratio x2.90 7,567.4%  
Inventory Days Days3621 171.4%  
Debtors Days Days2915 198.0%  
Net fixed assets Rs m4,7981,864 257.4%   
Share capital Rs m4211,709 24.6%   
"Free" reserves Rs m40,527-1,249 -3,244.5%   
Net worth Rs m40,947470 8,715.9%   
Long term debt Rs m0960 0.0%   
Total assets Rs m60,6816,249 971.1%  
Interest coverage x1,939.8-67.8 -2,861.2%   
Debt to equity ratio x02.0 0.0%  
Sales to assets ratio x0.80.1 642.9%   
Return on assets %16.2-61.6 -26.3%  
Return on equity %24.0-829.5 -2.9%  
Return on capital %37.0-276.9 -13.3%  
Exports to sales %05.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA41 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,17141 7,659.2%   
Fx outflow Rs m1,7700 1,609,136.4%   
Net fx Rs m1,40141 3,392.7%   
CASH FLOW
From Operations Rs m6,71140 16,903.5%  
From Investments Rs m-3,351NA 1,675,300.0%  
From Financial Activity Rs m-3,768-42 8,907.8%  
Net Cashflow Rs m-408-3 15,103.7%  

Share Holding

Indian Promoters % 0.0 31.7 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 12.0 3.7 324.3%  
ADR/GDR % 0.0 26.7 -  
Free float % 14.8 37.9 39.1%  
Shareholders   26,457 4,554 581.0%  
Pledged promoter(s) holding % 0.0 41.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   RADICO KHAITAN  TATA COFFEE  GODFREY PHILLIPS  VENKYS (I) LIMITED  REI AGRO.  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Rising Bad Loans, September Quarter Results, and Top Buzzing Stocks Today(Pre-Open)

Share markets in India ended marginally higher on Friday. At the closing bell on Friday, the BSE Sensex stood higher by 127 points (up 0.3%).

Related Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY19); Net Profit Up 34.9% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 34.9% YoY). Sales on the other hand came in at Rs 13 bn (up 9.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Feb 18, 2019 | Updated on Feb 18, 2019

For the quarter ended December 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 35.1% YoY). Sales on the other hand came in at Rs 11 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

My View on ITC(Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now(Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity(Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About(Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS